Few biologics in the US have multiple biosimilar competitors, but originator biologics respond quickly to competition by ...

Early adopters of biosimilars have paved the way for broader acceptance by sharing real-world success strategies, overcoming initial resistance, and highlighting best practices for integration and ...

Number 5: In 2 randomized controlled trials of maintenance therapy for inflammatory bowel disease (IBD), the subcutaneous formulation of the infliximab biosimilar CT-P13 demonstrated superiority to ...

Biosimilars could improve access to biologic treatments and health care sustainability in Latin America, but their adoption ...

This webinar celebrating Global Biosimilars Week was hosted by The Center for Biosimilars® in partnership with the International Generics and Biosimilars Association. This webinar celebrating Global ...

Although financial incentives introduced by Japan's 2022 health policy did not result in a reduction in overall drug costs, ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...